GALAXYSURFNSEMay 16, 2025

Galaxy Surfactants Limited

5,460words
5turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
bai – 400 051 Scrip Symbol: GALAXYSURF BSE Limited, Listing Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400001 Scrip Code: 540935 Sub: Investor presentation on the Audited Financ
₹21,715,
Volume growth was low single digit for Q4FY25 and FY25 on YoY basis, EBITDA/MT for Q4FY25 stood at ₹21,715, an increase of 24% on QoQ and for FY25 was at ₹19,868, broadly in line with FY24 Record Quarterly
24%
ingle digit for Q4FY25 and FY25 on YoY basis, EBITDA/MT for Q4FY25 stood at ₹21,715, an increase of 24% on QoQ and for FY25 was at ₹19,868, broadly in line with FY24 Record Quarterly volumes of ROW dri
₹19,868,
on YoY basis, EBITDA/MT for Q4FY25 stood at ₹21,715, an increase of 24% on QoQ and for FY25 was at ₹19,868, broadly in line with FY24 Record Quarterly volumes of ROW driven by masstige categories AMET volu
11.0%
e to affect operational consistency 4 FY25 Consolidated Performance Highlights Total Revenue* +11.0% 4,249.5 3,829.8 EBITDA +2.5% Rs. In Crores PAT +1.1% 497.7 510.0 301.5 304.9 FY24 FY25
2.5%
y 4 FY25 Consolidated Performance Highlights Total Revenue* +11.0% 4,249.5 3,829.8 EBITDA +2.5% Rs. In Crores PAT +1.1% 497.7 510.0 301.5 304.9 FY24 FY25 FY24 FY25 FY24 FY25 *Includ
1.1%
formance Highlights Total Revenue* +11.0% 4,249.5 3,829.8 EBITDA +2.5% Rs. In Crores PAT +1.1% 497.7 510.0 301.5 304.9 FY24 FY25 FY24 FY25 FY24 FY25 *Includes other Income 5 Q4FY25
21.0%
Y24 FY25 *Includes other Income 5 Q4FY25 Consolidated Performance Highlights Total Revenue* +21.0% 1,045.7 952.9 1,152.7 125.6 EBITDA +7.3% 109.5 134.7 77.5 Rs. In Crores 75.9 PAT -2.1%
7.3%
solidated Performance Highlights Total Revenue* +21.0% 1,045.7 952.9 1,152.7 125.6 EBITDA +7.3% 109.5 134.7 77.5 Rs. In Crores 75.9 PAT -2.1% 64.6 Q4FY24 Q3FY25 Q4FY25 Q4FY24 Q3FY25
2.1%
1.0% 1,045.7 952.9 1,152.7 125.6 EBITDA +7.3% 109.5 134.7 77.5 Rs. In Crores 75.9 PAT -2.1% 64.6 Q4FY24 Q3FY25 Q4FY25 Q4FY24 Q3FY25 Q4FY25 Q4FY24 Q3FY25 Q4FY25 *Includes other Inco
Rs. 2,590.8
wise Revenue & Volume Performance Region-wise Volume Performance Performance Surfactants Revenue Rs. 2,590.8 cr + Specialty Care Revenue Rs. 1,658.6 Total Revenue Rs. 4,249.5 cr Performance Surfactants
Rs. 1,658.6
se Volume Performance Performance Surfactants Revenue Rs. 2,590.8 cr + Specialty Care Revenue Rs. 1,658.6 Total Revenue Rs. 4,249.5 cr Performance Surfactants Specialty Care Mid single digit volume grow
Guidance — 5 items
Communication Address
opening
No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company.
Communication Address
opening
In Crores PAT +1.1% 497.7 510.0 301.5 304.9 FY24 FY25 FY24 FY25 FY24 FY25 *Includes other Income 5 Q4FY25 Consolidated Performance Highlights Total Revenue* +21.0% 1,045.7 952.9 1,152.7 125.6 EBITDA +7.3% 109.5 134.7 77.5 Rs.
Communication Address
opening
In Crores 75.9 PAT -2.1% 64.6 Q4FY24 Q3FY25 Q4FY25 Q4FY24 Q3FY25 Q4FY25 Q4FY24 Q3FY25 Q4FY25 *Includes other Income 6 FY25 Segment Performance Highlights Segment-wise Revenue & Volume Performance Region-wise Volume Performance Performance Surfactants Revenue Rs.
Communication Address
opening
4,249.5 cr Performance Surfactants Specialty Care Mid single digit volume growth vs Previous Year volumes were flat vs Previous Year INDIA Flat vs Previous Year AMET Flat vs Previous Year ROW High double digit volume growth vs Previous Year 7 Consolidated Profit & Loss Statement Q-o-Q 9.9% FY25 FY24 4,223.7 3,794.4 Particulars (Rs.
Cash Flow From Operating Activities
opening
Global Headquarters India Egypt:100% owned* Manufacturing R&D # Plants # Employees Marketing office ✓  1 400+  India: Parent Entity Manufacturing R&D # Plants ✓ ✓ 5 # Employees Marketing office 1,550+ ✓ Presence in High Growth & Matured Markets Incorporated in FY25 22 “Consumer to Chemistry”: Creation of Products Idea Stage r - - - - - - - - - - - - - - -.
Advertisement
Risks & concerns — 3 flagged
33 Corporate Governance Governance Structure Shareholders Board of Directors Audit Committee Nomination & Remuneration Committee Stakeholder’s Relationship Committee Corporate Social Responsibility Committee Risk Management Committee Management Team Organization 34 Board Members Mr.
Cash Flow From Operating Activities
Madhavan Hariharan Non-Executive Independent Director • Qualified CA, CS and CISA, He has also done multiple leadership programs at Harvard, Wharton and IIM • He brings over 30+ years of experience in the field of finance strategy, governance and risk management Ms.
Cash Flow From Operating Activities
Fatty Alcohol Prices (USD / MT) INR / USD Prices LA Price USDINR 3,000 2,600 2,200 1,800 1,400 1,000 90.00 86.00 82.00 78.00 74.00 70.00 LA Price USDINR … through Robust Risk Management Practices Source: Market Prices – ICIS – LOR Source: RBI 41 Our Performance Highlights Total Revenue (Rs.
Cash Flow From Operating Activities
Speaking time
Cash Flow From Operating Activities
2
Communication Address
1
Company
1
Investor Relations Advisors
1
Advertisement
Opening remarks
Communication Address
Rupa Solitaire, Ground Floor, Unit no. 8, 12A and 14 Millennium Business Park, Mahape, Navi Mumbai, 400 710 Ph: +91-22-33063700 Regd. Office: C-49/2, TTC Industrial Area, Pawne, Navi Mumbai-400 703, India CIN: L39877MH1986PLC039877 Ph: +91-22-27616666 Fax : +91-22-27615883/ 27615886 e-mail : galaxy@galaxysurfactants.com Website: www.galaxysurfactants.com ' h +'3, ,, ,, ,....., i (f� ,,.,:�\-. ,, . " � . __ ,. '' --c. ' , [' \ >? P'd - to6at Sag±lie ta to6at 3ad Galaxy Surfactants Limited Investor Presentation - May’25 - I A Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Galaxy Surfactants Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be
Cash Flow From Operating Activities
Profit After Tax Operating Profit before working Capital changes Net cash flows generated from/(used) in Operating Activities (A) Net cash flows generated from/(used) in Investing Activities (B) Net cash flows generated from/(used) in Financing Activities (C) Net Increase/(Decrease) in cash and cash equivalents (A+B+C) Opening cash and cash equivalents Effects of exchange rate changes on the balance of cash and cash equivalents held in foreign currencies Closing cash and cash equivalents FY25 FY24 304.9 484.5 420.5 -294.6 -157.3 -31.4 220.5 4.3 193.4 301.5 485.5 518.4 -343.9 -188.9 -14.4 231.9 3.0 220.5 10 Standalone Profit & Loss Statement Particulars (Rs. In Crores) Q4FY25 Q4FY24 Net Revenue from Operations Other Income Total Revenue Cost of Material Consumed Employee's Benefits Expense Other Expenses EBITDA EBITDA Margin Depreciation EBIT Finance cost PBT Tax expense PAT PAT Margin Other Comprehensive Income Total Comprehensive Income 814.3 6.7 820.9 608.2 40.6 90.5 81.7 705.7 4.4 7
Cash Flow From Operating Activities
Profit After Tax Operating Profit before working Capital changes Net cash flows generated from/(used) in Operating Activities (A) Net cash flows generated from/(used) in Investing Activities (B) Net cash flows generated from/(used) in Financing Activities (C) Net Increase/(Decrease) in cash and cash equivalents (A+B+C) Opening cash and cash equivalents Effects of exchange rate changes on the balance of cash and cash equivalents held in foreign currencies Closing cash and cash equivalents FY25 FY24 173.8 282.7 295.5 -164.8 -143.6 -13.0 21.9 0.0 8.9 200.3 319.3 238.4 -142.4 -95.8 0.2 21.7 0.0 21.9 13 Business Overview q " . .. 14 Truly Indian MNC… Leading manufacturer of ingredients for Home and Personal Care Industries Product applications across Mass, Masstige & Prestige range of Customers Preferred supplier to leading Multinational, Regional & Local FMCG Brands Brand Custodian Globally Recognized Integrated Across Full Value Chain of HPC Industry Advanced portfolio of Innovative Produ
Investor Relations Advisors
$GA8«et Go«h nisors CIN No: L39877MH1986PLC039877 CIN - U74140MH2010PTC204285 Mr. Paritosh Srivastava Email: Paritosh.Srivastava@galaxysurfactants.com www.galaxysurfactants.com Mr. Mandar Chavan / Mr. Rahul Agarwal mandar.chavan@sgapl.net / rahul.agarwal@sgapl.net +91 96993 82195 / +91 98214 38864 www.sgapl.net 44
Advertisement
← All transcriptsGALAXYSURF stock page →